These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


527 related items for PubMed ID: 25400825

  • 1. Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.
    Lu QY, Chen W, Lu L, Zheng Z, Xu X.
    Int J Clin Exp Pathol; 2014; 7(10):7268-77. PubMed ID: 25400825
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
    Peng H, Luo P, Li Y, Wang C, Liu X, Ye Z, Li C, Lou T.
    PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
    [Abstract] [Full Text] [Related]

  • 3. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L, Wang W, Xie TH, Zou J, Nie X, Wang X, Zhang MY, Wang ZY, Gu S, Zhuang M, Tan J, Shen C, Dai Y, Yang X, Yao Y, Wei TT.
    FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
    [Abstract] [Full Text] [Related]

  • 4. High Glucose Aggravates Retinal Endothelial Cell Dysfunction by Activating the RhoA/ROCK1/pMLC/Connexin43 Signaling Pathway.
    Zhao H, Kong H, Wang W, Chen T, Zhang Y, Zhu J, Feng D, Cui Y.
    Invest Ophthalmol Vis Sci; 2022 Jul 08; 63(8):22. PubMed ID: 35881407
    [Abstract] [Full Text] [Related]

  • 5. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.
    Diabetes; 2009 Jan 08; 58(1):215-26. PubMed ID: 18840783
    [Abstract] [Full Text] [Related]

  • 6. RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.
    Lu Q, Lu L, Chen W, Chen H, Xu X, Zheng Z.
    Graefes Arch Clin Exp Ophthalmol; 2015 May 08; 253(5):669-80. PubMed ID: 25791356
    [Abstract] [Full Text] [Related]

  • 7. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
    Mangialardi G, Katare R, Oikawa A, Meloni M, Reni C, Emanueli C, Madeddu P.
    Arterioscler Thromb Vasc Biol; 2013 Mar 08; 33(3):555-64. PubMed ID: 23307872
    [Abstract] [Full Text] [Related]

  • 8. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
    Cheng CI, Chen PH, Lin YC, Kao YH.
    Cell Signal; 2015 Feb 08; 27(2):283-92. PubMed ID: 25446262
    [Abstract] [Full Text] [Related]

  • 9. Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitro.
    Zhou M, Li G, Zhu L, Zhou H, Lu L.
    J Cell Mol Med; 2020 May 08; 24(10):5695-5706. PubMed ID: 32297701
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH, Xu XH, Luo Q, Zhang HL, Wang Y, Xi QY, Zhao ZH, Liu ZH.
    Clin Exp Hypertens; 2018 May 08; 40(3):224-230. PubMed ID: 29319354
    [Abstract] [Full Text] [Related]

  • 11. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
    Yang L, Tang L, Dai F, Meng G, Yin R, Xu X, Yao W.
    Toxicology; 2017 Aug 15; 389():74-84. PubMed ID: 28743511
    [Abstract] [Full Text] [Related]

  • 12. Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling Pathway.
    Wang X, Zhao X, Feng T, Jin G, Li Z.
    Planta Med; 2016 Sep 15; 82(14):1252-7. PubMed ID: 27552253
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH, Kim JH, Jun HO, Yu YS, Kim KW.
    Am J Pathol; 2010 Mar 15; 176(3):1517-24. PubMed ID: 20110406
    [Abstract] [Full Text] [Related]

  • 14. A Positive Feedback Loop of Profilin-1 and RhoA/ROCK1 Promotes Endothelial Dysfunction and Oxidative Stress.
    Li X, Liu J, Chen B, Fan L.
    Oxid Med Cell Longev; 2018 Mar 15; 2018():4169575. PubMed ID: 29849894
    [Abstract] [Full Text] [Related]

  • 15. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H, Chen X, Han Y, Li C, Chen P, Su S, Zhang Y, Pan Z.
    Biomed Pharmacother; 2014 Apr 15; 68(3):267-75. PubMed ID: 24406296
    [Abstract] [Full Text] [Related]

  • 16. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun 15; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
    Xu XT, Song QB, Yao Y, Ruan P, Tao ZZ.
    Hepatogastroenterology; 2012 Jun 15; 59(120):2523-6. PubMed ID: 22584506
    [Abstract] [Full Text] [Related]

  • 18. S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1.
    Chen W, Xiang H, Chen R, Yang J, Yang X, Zhou J, Liu H, Zhao S, Xiao J, Chen P, Chen AF, Chen S, Lu H.
    BMC Nephrol; 2019 Apr 18; 20(1):135. PubMed ID: 30999892
    [Abstract] [Full Text] [Related]

  • 19. Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
    Yin Q, Xia Y, Wang G.
    Biochem Biophys Res Commun; 2016 Sep 02; 477(4):881-886. PubMed ID: 27378427
    [Abstract] [Full Text] [Related]

  • 20. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
    Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC.
    Diabetes; 2008 Jun 02; 57(6):1683-92. PubMed ID: 18356410
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.